Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report?
Clover Health Investments (CLOV) reported earnings 30 days ago. What's next for the stock?
Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits
Despite disappointing YTD earnings due to higher than expected medical costs, Clover's expected GAAP profitability in 2026 marks a critical inflection point. Clover's higher returning member mix and targeted growth measures aiming to bring more members under Clover Assistant quicker are major tailwinds to medical costs next year, in my opinion. Clover Assistant's early diagnosis capabilities set the company up to benefit from the CMS' Part D measures aiming to normalize cost pressures on plans, in my opinion.
Clover Health Investments, Corp. (CLOV) Presents at UBS Global Healthcare Conference 2025 Transcript
Clover Health Investments, Corp. ( CLOV ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst Okay. All right.
Why Fast-paced Mover Clover Health Investments (CLOV) Is a Great Choice for Value Investors
Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View
Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment.
Clover Health Investments, Corp. (CLOV) Q3 2025 Earnings Call Transcript
Clover Health Investments, Corp. ( CLOV ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Peter Kuipers - Chief Financial Officer Conference Call Participants Jonathan Yong Presentation Operator Hello, and welcome to Clover Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Also, as a reminder, this conference is being recorded today.
Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3
Clover Health Investments, Corp. (CLOV) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.02. This compares to a loss of $0.02 per share a year ago.
Clover Health Surges: Profit, Revenue, Membership Up
Clover Health Investments (NASDAQ: CLOV) delivered its second consecutive profitable quarter tonight, beating earnings expectations and extending a streak of operational improvement that has quietly reshaped the Medicare Advantage insurer's narrative.
Clover Health Investments (CLOV) Upgraded to Buy: Here's What You Should Know
Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Fast-paced Momentum Stock Clover Health Investments (CLOV) Is Still Trading at a Bargain
Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
Clover Health Investments (CLOV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
